Abstract:Background: Chronic use of mu-opioid receptor agonists paradoxically causes both hyperalgesia and the loss of analgesic efficacy. Opioid treatment increases presynaptic N-methyl-d-aspartate receptor activity to potentiate nociceptive input to spinal dorsal horn neurons. However, the mechanism responsible for this opioid- induced activation of presynaptic N-methyl-d-aspartate receptors remains unclear. alpha 2 delta-1, formerly known as a calcium channel subunit, interacts with N-methyl-d-aspartate receptors and is primarily expressed at presynaptic terminals. This study tested the hypothesis that alpha 2 delta-1-bound N-methyl-d-aspartate receptors contribute to presynaptic N-methyl-d-aspartate receptor hyperactivity associated with opioid-induced hyperalgesia and analgesic tolerance. Methods: Rats (5 mg/kg) and wild-type and alpha 2 delta-1-knockout mice (10 mg/kg) were treated intraperitoneally with morphine twice/day for 8 consecutive days, and nociceptive thresholds were examined. Presynaptic N-methyl-d-aspartate receptor activity was recorded in spinal cord slices. Coimmunoprecipitation was performed to examine protein-protein interactions. Results: Chronic morphine treatment in rats increased alpha 2 delta-1 protein amounts in the dorsal root ganglion and spinal cord. Chronic morphine exposure also increased the physical interaction between alpha 2 delta-1 and N-methyl-d-aspartate receptors by 1.5 +/- 0.3 fold (means +/- SD, P = 0.009, n = 6) and the prevalence of alpha 2 delta-1-bound N-methyl-d-aspartate receptors at spinal cord synapses. Inhibiting alpha 2 delta-1 with gabapentin or genetic knockout of alpha 2 delta-1 abolished the increase in presynaptic N-methyl-d-aspartate receptor activity in the spinal dorsal horn induced by morphine treatment. Furthermore, uncoupling the alpha 2 delta-1-Nmethyl- d-aspartate receptor interaction with an alpha 2 delta-1 C terminus-interfering peptide fully reversed morphine-induced tonic activation of N-methyl-d-aspartate receptors at the central terminal of primary afferents. Finally, intraperitoneal injection of gabapentin or intrathecal injection of an alpha 2 delta-1 C terminus-interfering peptide or alpha 2 delta-1 genetic knockout abolished the mechanical and thermal hyperalgesia induced by chronic morphine exposure and largely preserved morphine's analgesic effect during 8 days of morphine treatment. Conclusions: alpha 2 delta-1-Bound N-methyl-d-aspartate receptors contribute to opioid-induced hyperalgesia and tolerance by augmenting presynaptic N-methyl-d-aspartate receptor expression and activity at the spinal cord level.

High-dose Pentazocine Antagonizes the Antinociception Induced by High-Dose Morphine

Pentazocine-induced Antinociception is Mediated Mainly by Μ-Opioid Receptors and Compromised by Κ-Opioid Receptors in Mice.

Influence Of Clonidine And Ketamine On M-Rna Expression In A Model Of Opioid-Induced Hyperalgesia In Mice

Effects of Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide, on the Antinociceptive Activity of Pethidine Administered at the Peripheral and Supraspinal Level

Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats

Role of Mu-Opioid Agonist Efficacy on Antinociceptive Interactions Between Mu Agonists and the Nociceptin Opioid Peptide Agonist Ro 64-6198 in Rhesus Monkeys.

Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain

Pentobarbital administered intracerebroventricularly antagonizes morphine-induced antinociception in mice

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

Involvements of Mu- and Kappa-Opioid Receptors in Morphine-Induced Antinociception in the Nucleus Accumbens of Rats

Morphine Antinociception Medullary Pain Modulating Neurons and Reduce Kappa Opioids Inhibit Physiologically Identified

Antagonistic Effect of Orphanin FQ on Opioid Analgesia in Rat

Comparative Study of Dezocine, Pentazocine and Tapentadol on Antinociception and Physical Dependence

Antagonism of Morphine-Induced Antinociception by Tetrandrine is Dependent on Serotonergic Mechanisms.

Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.

Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.

Nocistatin Reverses the Effect of Orphanin Fq/Nociceptin in Antagonizing Morphine Analgesia

Α2δ-1–Boundn-methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking

Comparative Pharmacological Profiles of Morphine and Oxycodone under a Neuropathic Pain-Like State in Mice: Evidence for Less Sensitivity to Morphine

Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery